Endometrial Cancer - Health Xplore

Thursday, 29 October 2026

Response Research to Emerging Infectious Diseases Inform

March 26, 2024

Skin Type Before Choosing Skin Care Products

March 26, 2024

Using Lemon on Your Face & Ways to

March 26, 2024

Most Common Exercise Machines at the Gym

March 26, 2024

Contact Info

E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com

Tag: Endometrial Cancer

New Drug Reduces Endometrial Cancer Progression Risk by 41%

News

Merck’s Sac-TMT Cuts Risk of Progression and Death in Endometrial Cancer

Women treated with Merck’s sacituzumab tirumotecan (sac-TMT) had a 41% lower risk of endometrial cancer progression than those receiving standard chemotherapy after immunotherapy, according to Phase 3 trial data.

imphoenix82
October 27, 2026
0 Comments
133 Views

About Us

HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.

Email: support@healthxploreindia.com

Contact: +91 9354115542

Response Research to Emerging Infectious Diseases Inform

Skin Type Before Choosing Skin Care Products

Using Lemon on Your Face & Ways to

Most Common Exercise Machines at the Gym

Contact Info

Tag: Endometrial Cancer

Merck’s Sac-TMT Cuts Risk of Progression and Death in Endometrial Cancer

BD Launches UltraCor Twirl Breast Tissue Markers in.

Roche Launches VENTANA BAP1 Test to Aid Mesothelioma.

FDA Expands Approval of Pfizer’s TALZENNA Plus XTANDI.

Lilly International President Patrik Jonsson to Retire; Ilya.

About Us

Quick Link

Top Categories

Top Posts

Laser Treatments for Anti-aging: Types, Benefits,

Lilly’s Retatrutide Shows Powerful Weight Loss

National Registry for Implantable Medical Devices: